Clusterin at the Ocular Surface
Clusterin at the Ocular Surface
批准号:
9755442
负责人:
M. Elizabeth Fini
金额:
$55.67万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-01 至 2021-06-30
关键词:
AddressAdverse effectsAffectAgingAnti-inflammatoryApicalBasic ScienceBindingBiochemicalBiological AssayBiological Response Modifier TherapyBlindnessCellsCharacteristicsClinicalContact LensesCorneaCyclosporineCytoprotectionDataDiseaseDropsDry Eye SyndromesEnvironmentEnvironmental ExposureEpithelialEpitheliumExperimental ModelsEyeGalactose Binding LectinGalectin 3GenesGeneticGlycocalyxGlycoproteinsHumanHydration statusIn VitroInflammationInflammatoryJournalsKnockout MiceKnowledgeLeftLightLiquid substanceLubricationMMP9 geneMeasurementMedicalMedicineMethodsModelingMolecularMusNatureOperative Surgical ProceduresOphthalmologic Surgical ProceduresPainPathway interactionsPatientsPenetrationPeptidesPharmaceutical PreparationsPositioning AttributePropertyProteinsProteolysisPruritusPublishingRednessResearchResearch PersonnelRoleSquamous MetaplasiaStressStructureSurfaceSymptomsTherapeuticTissuesUnited States Food and Drug AdministrationUnited States National Institutes of HealthWorkcorneal epitheliumcorneal scareye drynessin vivoinflammatory milieuinnovationintercalationmouse modelnovelnovel strategiesnovel therapeuticsocular surfacepreventproteostasisresponsesealsulfated glycoprotein 2tear proteins
中文摘要
点击翻译按钮获取中文摘要
英文摘要
7. PROJECT SUMMARY/ ABSTRACT
Dry eye syndrome is a common affliction of the eye that affects millions of people. Dry eye is brought on by
aging, eye surgery or environmental exposure and is also an adverse effect of contact lens wear, and topical
eye medications. Symptoms include pain, burning, itching, redness, sensitivity to light and other discomfort. If
left untreated, severe cases may result in vision loss due to corneal scarring. New research from this research
team, recently published in the NIH-supported journal PLOS ONE, suggests a new approach to treating dry
eye. Using an experimental mouse model, the researchers found that the natural tear protein known as
clusterin selectively binds to the ocular surface barrier disrupted by desiccating stress in an all-or-none
manner, while also preventing further damage. Known properties of clusterin suggest it may further protect
against the upstream effects of inflammatory cascade activation and subsequent squamous metaplasia. The
proposed research will investigate this previously unrecognized, endogenous protective mechanism. The
planned studies make use of the mouse experimental model and a quantitative functional assay for ocular
surface barrier disruption, and take advantage of mouse genetics. The specific aims are: 1) to determine the
molecular nature of clusterin intercalation into the ocular surface glycocalyx, and how it might relate to the all-
or-none effect; 2) to document the role of clusterin in anti-proteolysis, the effects of proteolysis on the capacity
for clusterin binding, and the relationship between the proteolytic and clusterin pathways; 3) to define the
endogenous clusterin protection pathway and its role in maintaining an anti-inflammatory environment at the
ocular surface. The impact of this research will be new basic science knowledge about the ocular surface
barrier, how it is altered in disease, and mechanisms of protection by clusterin. The results will set the stage for
clinical innovation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mitochondria and Mustard Damage at the Ocular Surface
-
批准号:10708498
-
项目类别:
-
资助金额:$53.74万
-
财政年份:2023
-
负责人:M. Elizabeth Fini
-
依托单位:
Dynasore Analogues for Ocular Surface Protection
-
批准号:10310762
-
项目类别:
-
资助金额:$10.87万
-
财政年份:2019
-
负责人:M. Elizabeth Fini
-
依托单位:
Dynasore Analogues for Ocular Surface Protection
-
批准号:10004039
-
项目类别:
-
资助金额:$22.33万
-
财政年份:2019
-
负责人:M. Elizabeth Fini
-
依托单位:
Protection and Treatment of the Ocular Surface Barrier
-
批准号:9334035
-
项目类别:
-
资助金额:$8.0万
-
财政年份:2017
-
负责人:M. Elizabeth Fini
-
依托单位:
Discovery Approach to Ocular Hypertension
-
批准号:9921393
-
项目类别:
-
资助金额:$59.29万
-
财政年份:2017
-
负责人:M. Elizabeth Fini
-
依托单位:
Discovery Approach to Ocular Hypertension
-
批准号:9333672
-
项目类别:
-
资助金额:$59.65万
-
财政年份:2017
-
负责人:M. Elizabeth Fini
-
依托单位:
Discovery Approach to Ocular Hypertension
-
批准号:9751867
-
项目类别:
-
资助金额:$59.29万
-
财政年份:2017
-
负责人:M. Elizabeth Fini
-
依托单位:
Clusterin at the Ocular Surface
-
批准号:9329433
-
项目类别:
-
资助金额:$51.61万
-
财政年份:2016
-
负责人:M. Elizabeth Fini
-
依托单位:
Clusterin at the Ocular Surface
-
批准号:9196261
-
项目类别:
-
资助金额:$51.61万
-
财政年份:2016
-
负责人:M. Elizabeth Fini
-
依托单位:
Miami Center for Vision Research
-
批准号:6888034
-
项目类别:
-
资助金额:$58.36万
-
财政年份:2004
-
负责人:M. Elizabeth Fini
-
依托单位:
CORE--EQUIPMENT
-
批准号:6985840
-
项目类别:
-
资助金额:$8.4万
-
财政年份:2004
-
负责人:M. Elizabeth Fini
-
依托单位:
AFMINISTRATION
-
批准号:6985838
-
项目类别:
-
资助金额:$3.29万
-
财政年份:2004
-
负责人:M. Elizabeth Fini
-
依托单位:
Miami Center for Vision Research
-
批准号:6797085
-
项目类别:
-
资助金额:$22.27万
-
财政年份:2004
-
负责人:M. Elizabeth Fini
-
依托单位:
Miami Center for Vision Research
-
批准号:7061202
-
项目类别:
-
资助金额:$59.87万
-
财政年份:2004
-
负责人:M. Elizabeth Fini
-
依托单位:
Supplement to Core Grant for Vision Research
-
批准号:6494562
-
项目类别:
-
资助金额:$51.14万
-
财政年份:2002
-
负责人:M. Elizabeth Fini
-
依托单位:
Core Grant for Vision Research
-
批准号:6346517
-
项目类别:
-
资助金额:$39.97万
-
财政年份:2001
-
负责人:M. Elizabeth Fini
-
依托单位:
METALLOPROTEINASES AND FAILURE TO RE-EPITHELIALIZE
-
批准号:2082550
-
项目类别:
-
资助金额:$18.71万
-
财政年份:1994
-
负责人:M. Elizabeth Fini
-
依托单位:
METALLOPROTEINASES AND FAILURE TO RE-EPITHELIALIZE
-
批准号:2082549
-
项目类别:
-
资助金额:$19.16万
-
财政年份:1994
-
负责人:M. Elizabeth Fini
-
依托单位:
Maintenance of Ocular Surface Integrity
-
批准号:6686925
-
项目类别:
-
资助金额:$30.3万
-
财政年份:1994
-
负责人:M. Elizabeth Fini
-
依托单位:
Maintenance of Ocular Surface Integrity
-
批准号:6927205
-
项目类别:
-
资助金额:$43.28万
-
财政年份:1994
-
负责人:M. Elizabeth Fini
-
依托单位:
海外基金